Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
出版年份 2019 全文链接
标题
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
作者
关键词
Ulcerative colitis, Monoclonal antibody, Infliximab, Target-mediated drug disposition
出版物
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-07
DOI
10.1007/s10928-019-09652-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay
- (2019) Lea C. Berkhout et al. Science Translational Medicine
- Pharmacokinetic and pharmacodynamic model for analysis of adalimumab administered for Crohn's disease
- (2018) Koji Kimura et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Synergistic Cytokine Effects as Apremilast Response Predictors in Patients With Psoriasis
- (2018) Sandra Garcet et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
- (2016) Johannan F. Brandse et al. Clinical Gastroenterology and Hepatology
- Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum
- (2016) David Yeung et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange
- (2016) Karin A. van Schie et al. Scientific Reports
- Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice
- (2015) D. J. Buurman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum
- (2012) Shui-Long Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Ulcerative colitis
- (2012) Ingrid Ordás et al. LANCET
- Single molecule measurements of tumor necrosis factor α and interleukin-6 in the plasma of patients with Crohn's disease
- (2011) Linan Song et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Theory-based analysis of anti-inflammatory effect of infliximab on Crohn’s disease and rheumatoid arthritis
- (2010) Koji Kimura et al. RHEUMATOLOGY INTERNATIONAL
- Identification of Key Processes that Control Tumor Necrosis Factor Availability in a Tuberculosis Granuloma
- (2010) Mohammad Fallahi-Sichani et al. PLoS Computational Biology
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Approximations of the target-mediated drug disposition model and identifiability of model parameters
- (2008) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search